Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Kasparek Anne-Katrin |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA.
[Poster]
Pondorfer, P; Mollnar, S; Kasparek A; Reinisch, S; Moik, F; Stolz, M; Halm, M; Szkandera, J; Gerger; A; Kapp, K; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D;
Induction chemotherapy and chemoradiation for patients with advanced HNSCC: A systematic analysis of acute treatment toxicities and their management
https://www.hno.at/fileadmin/userdaten/HNO_Kongress_2019/HNO2019_Abstractband_web_20190828.pdf. 2019; -Österreichischer HNO Kongress; Sep 11-15, 2019; Salzburg.
[Oral Communication]
FullText
Pondorfer, P; Molnar, S Kasparek, A.-K.; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Berger, A; Kapp, K.S;
Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D;
HPV infection as a predictive biomarker for response to induction chemotherapy and concomitant chemoradiation in patients with advanced head and neck squamous cell carcinoma
CEORL HNS; JUN 30, 2019; Brussels. 2019.
[Oral Communication]
FullText
Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F
Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248.
[Poster]
Web of Science
Eisner, F; Suppan, C; Kasparek, AK; Samonigg, H; Höfler, G; Zigeuner, R; Bauernhofer, T
Partielle Remission unter Therapie mit Everolimus bei 51jähriger Patientin mit Lymphangioleiomyomatose.
ÖGHO Frühjahrstagung ; APR 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Keil, F; Selzer, E; Berghold, A; Reinisch, S; de Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsasser, W; Kainz, H; Riedl, R; Kapp, K; Kopp, M; Kornek, G
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
ONCOL RES TREAT. 2014; 37: 273-273.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie.; Oct 10-14, 2014; Hamburg, Deutschland.
[Oral Communication]
Web of Science
Karpf, EF; Koele W; Kasparek, AK; Beham, A
Gingival metastasis as primary manifestation of a gonadal tumor.
52. Österreichischer HNO-Kongress 2008.; SEP 10 - 14, 2008; Graz. 2008.
[Poster]
Kasparek, AK
Nebenwirkungen und Komplikationen der Tumortherapie. Onkologische Pflegefortbildung 2007/2008
; Apr 24, 2008, Apr 28, 2008; Graz, Austria. 2008.
[Oral Communication]
Kasparek, AK
Nebenwirkungen und Komplikationen der Tumortherapie.
Onkologische Pflegefortbildung 2006/2007; APR 26, 2007, MAY 3, 2007; Graz, AUSTRIA. 2007.
[Oral Communication]
Kasparek, AK
Nebenwirkungen und Komplikationen der Tumortherapie
; APR 20, 27; Graz. 2006.
[Oral Communication]
Samonigg, H; Andritsch, E; Dietmaier, G; Bauernhofer, T; Andritsch, H; Zloklikovits, S; Kasparek, AK; Stoeger, H; Schaberl-Moser, R; Ploner, F
Healing by Design: the Influence of an Artistic Design on the Wellbeing of Cancer Patients-- a 10 Years Follow Up.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. (June 20 Supplement); 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Kuss, I; Wagner, P; Genser, B; Stöger, H; Kasparek, AK; Samonigg, H
Low dose weekly anthracycline chemotherapy for breast cancer patients with bone marrow infiltration.
ANN ONCOL 2000 11: 38-38.
Web of Science
Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
SAMONIGG, H; SCHEITHAUER, W; DEPISCH, D; WIEGELE, J; SCHULLER, J; HAUSMANNINGER, H; LUDWIG, H; STOGER, H; PREIS, P; KASPAREK, AK; ZIELINSKI, C
PHASE-II STUDY - PIRARUBICIN (4-O-TETRAHYDRO-PYRANYL-ADRIAMYCIN THP) IN ADVANCED BREAST-CANCER
BLUT. 1988; 57(4): 206-206.
Web of Science
SAMONIGG, H; STOGER, H; KASPAREK, AK
A PHASE-II-STUDY - COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE
BLUT. 1987; 55(4): 362-362.
Web of Science
STOGER, H; KASPAREK, AK; SAMONIGG, H
PREOPERATIVE POLYCHEMOTHERAPY WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE FOR INFLAMMATORY BREAST-CANCER
BLUT. 1987; 55(4): 363-363.
Web of Science